Comparison between Allchem Lifescience IPO and BMW Ventures IPO.
Allchem Lifescience IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while BMW Ventures IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Allchem Lifescience IPO is up to ₹0.00 Cr whereas the issue size of the BMW Ventures IPO is up to ₹231.66 Cr. The final issue price of Allchem Lifescience IPO is and of BMW Ventures IPO is ₹99.00 per share.
| Allchem Lifescience IPO | BMW Ventures IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹94.00 per share | |
| Issue Price (Upper) | ₹99.00 per share | |
| Issue Price (Final) | ₹99.00 per share | |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 151 shares | |
| Fresh Issue Size | 0 shares | 2,34,00,000 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹231.66 Cr |
| OFS Issue Size | 71,55,000 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 0 shares | 2,34,00,000 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹231.66 Cr |
Allchem Lifescience IPO opens on , while BMW Ventures IPO opens on Sep 24, 2025. The closing date of Allchem Lifescience IPO and BMW Ventures IPO is , and Sep 26, 2025, respectively.
| Allchem Lifescience IPO | BMW Ventures IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Sep 24, 2025 | |
| Issue Close | Sep 26, 2025 | |
| Basis Of Allotment (Tentative) | Sep 29, 2025 | |
| Initiation of Refunds (Tentative) | Sep 29, 2025 | |
| Credit of Share (Tentative) | Sep 30, 2025 | |
| Listing date (Tentative) | Oct 01, 2025 | |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Allchem Lifescience IPO P/E ratio is , as compared to BMW Ventures IPO P/E ratio of 19.1.
| Allchem Lifescience IPO | BMW Ventures IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated)BMW Ventures Ltd.'s revenue increased by 6% and profit after tax (PAT) rose by 10% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100 | 100 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 73.02 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 19.1 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹858.48 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 34.33% | 15.62% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 22.87% | 12.80% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.31 | 2.04 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹3.06 | ₹5.18 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 34.33% | 16.54% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Allchem Lifescience IPO Retail Individual Investors (RII) are offered while in BMW Ventures IPO retail investors are offered . Qualified Institutional Buyers (QIB) are offered in Allchem Lifescience IPO and 2,34,000 shares in BMW Ventures IPO.
| Allchem Lifescience IPO | BMW Ventures IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | |
| Market Maker Reservation | 0 shares | |
| QIB | 2,34,000 shares | |
| NII | 56,16,000 shares | |
| RII | 1,75,50,000 shares | |
| Employee | 0 shares | |
| Others | ||
| Total | 2,34,00,000 shares |
Allchem Lifescience IPO subscribed in total, whereas BMW Ventures IPO subscribed 1.50x.
| Allchem Lifescience IPO | BMW Ventures IPO | |
|---|---|---|
| QIB (times) | 3.09x | |
| NII (times) | 3.03x | |
| Big NII (times) | 3.41x | |
| Small NII (times) | 2.27x | |
| RII (times) | 0.99x | |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 1.50x |
